Skye Bioscience, Inc. (OTCMKTS:SKYE) Sees Large Growth in Short Interest

Skye Bioscience, Inc. (OTCMKTS:SKYEGet Rating) was the recipient of a significant increase in short interest in May. As of May 15th, there was short interest totalling 44,700 shares, an increase of 84.7% from the April 30th total of 24,200 shares. Based on an average trading volume of 2,032,700 shares, the days-to-cover ratio is presently 0.0 days.

Skye Bioscience Price Performance

Skye Bioscience stock remained flat at $0.02 during midday trading on Friday. 364,040 shares of the company’s stock traded hands, compared to its average volume of 1,622,016. The business’s 50 day simple moving average is $0.02 and its 200-day simple moving average is $0.02. Skye Bioscience has a 12-month low of $0.01 and a 12-month high of $0.06. The firm has a market capitalization of $14.57 million, a P/E ratio of -0.30 and a beta of 0.44.

Skye Bioscience Company Profile

(Get Rating)

Skye Bioscience, Inc is a biopharmaceutical company, which engages in the discovery, development and commercialization of cannabinoid-based therapeutics. It focuses on the treatment of a spectrum of diseases, as well as utilizing bioengineering in drug design. Its product pipeline includes SBI-100 and SBI-200.

Featured Stories

Receive News & Ratings for Skye Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Skye Bioscience and related companies with's FREE daily email newsletter.